Measuring Transparency to Improve Good Governance in the Public Pharmaceutical Sector: Syrian Arab R

In recent years, countries of the WHO Eastern Mediterranean Region have made significant achievements in the provision of health services. In the pharmaceutical field, countries have been striving to improve the structures and regulations pertaining to medicines and have progressed in many ways. However, there are still important challenges. The goal of the WHO Good Governance for Medicines program is to improve the situation of medicine regulation and supply. National transparency assessment is the beginning of a process aimed at bringing about desirable and sustainable changes in the governance of the pharmaceutical sector. These reports present the findings of the first phase of the national Good Governance for Medicines program in Jordan, Lebanon, Morocco, Pakistan and Syrian Arab Republic.